| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0005 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0009 |